Skip to main content
. 2026 Jan 26;34:e20250492. doi: 10.1590/1678-7765-2025-0492

Table 3. Association of gene polymorphisms with demographic features .

Variables Total   EBI3 EBI3 EBI3
  N=95   rs4740 rs4905 rs428253
      GG/GA/AA AA/AG/GG GG/GC/CC
Sex Male 76 42/19/15 41/23/12 43/30/3
Female 19 7/9/3 7/10/2 10/8/1
P   0.157 0.187 0.936
Age 58< 43 21/12/10 21/14/8 23/18/2
>58 52 28/16/8 27/19/6 30/20/2
P   0.622 0.622 0.914
Smoking Never 18 5/8/5 5/9/4 7/10/1
Current 68 39/19/10 38/21/9 40/25/3
Former 9 5/1/3 5/3/1 6/3/0
P   0.122 0.326 0.549
Alcohol No 52 24/18/10 24/22/6 28/23/1
Low 25 14/6/5 13/7/5 14/8/3
High 18 11/4/3 11/4/3 11/7/0
P   0.769 0.481 0.217
Tumor EBV status Negative 56 31/12/13 30/17/9 34/19/3
Positive 39 18/16/5 18/16/5 19/19/1
P   0.096 0.558 0.320
Tumor EBV viral load* Negative 56 30/12/14 29/17/10 33/19/4
Low 20 8/11/1 8/11/1 10/10/0
High 19 11/5/3 11/5/3 10/9/0
P   0.047 0.249 0.365
Tumor HCMV status Negative 88 47/25/16 46/30/12 51/33/4
Positive 7 2/3/2 2/3/2 2/5/0
P   0.448 0.397 0.203
Histological grade 1 65 29/23/13 29/27/9 32/32/1
2 16 11/3/2 11/3/2 13/0/3
3 14 9/2/3 8/3/3 8/6/0
P   0.299 0.298 0.001
Nuclear grade 1 55 29/19/10 25/23/7 30/24/1
2 20 11/6/3 11/6/3 11/7/2
3 20 12/3/5 12/4/4 12/7/1
P   0.560 0.491 0.578
Tumor size 1/2 65 35/20/10 34/23/8 39/25/1
3/4 30 14/8/8 14/10/6 14/13/3
P   0.427 0.613 0.118
Nodal status 0 34 15/15/4 14/17/3 18/15/1
1 50 28/9/13 28/12/10 29/18/3
2 11 6/4/1 6/4/1 6/5/0
P   0.082 0.144 0.827
Tumor stage I/II 29 12/14/3 11/16/2 15/13/1
III/I 66 37/14/15 37/17/12 38/25/3
P   0.024 0.018 0.809
Recurrence 0 38 19/13/6 18/15/5 24/13/1
1 57 30/15/12 30/18/9 29/25/3
P   0.655 0.726 0.467

* EBV viral load categories were defined as negative, low (below the median), and high (above the median), based on values calculated as 2(–ΔCt) x 200,000/10⁵ cells.